Long Covid Newsletter
Issue #50August 17, 20267 studies
A probiotic just beat placebo for long COVID fatigue in a randomized trial
Long COVID research had a busy week — and for once, a treatment actually worked in a controlled trial.
Here's what the evidence is saying right now.
A Probiotic Cut Long COVID Fatigue — in an Actual Randomized Trial 💊
- The VSL#3 probiotic formulation was tested against placebo in patients with long COVID, targeting the gut-immune axis that researchers increasingly suspect drives persistent symptoms.
- The trial found meaningful improvement in fatigue — one of long COVID's most stubborn and disabling features — making this one of the few randomized controlled trials to show a positive result in this space.
- The mechanism fits an emerging picture: gut microbiota dysbiosis and immune dysregulation appear to sustain symptoms long after the virus is gone, and VSL#3 targets that disruption directly.
Why it matters: Most long COVID interventions have flopped in controlled settings. A probiotic clearing that bar — however modest the trial — is worth watching.
Key Findings
One-Third of Saudi COVID Survivors Still Have Symptoms Months Later 🌍
- A nationally representative study of 1,790 adults across all 13 regions of Saudi Arabia found a 32% long COVID prevalence, with fatigue (68%), shortness of breath (45%), and cognitive impairment (39%) leading the symptom list.
- Female sex, moderate-to-severe acute illness, and incomplete vaccination each independently predicted who developed long COVID — and 12% of those affected reported work disability.
💡 One in three COVID survivors in Saudi Arabia still carries the burden.
Your Genetics May Predict How Your Brain Handles Post-Exertional Crashes 🧬
- In a study of 44 long COVID patients, those carrying two copies of the Hp2 variant of the haptoglobin gene showed significant cognitive decline after a 90-minute physical challenge — while Hp1-1 carriers stayed cognitively stable.
- The Hp2 group also had lower post-exertional levels of several metabolites linked to energy metabolism, and those lower levels tracked with worse cognitive performance.
💡 A common genetic variant may sort long COVID patients into very different cognitive trajectories.
Long COVID Rewires Balance and Core Strength — Not Just Energy ⚖️
- A study of 128 participants found that long COVID patients swayed significantly more on balance tests and had reduced trunk strength and range of motion compared to matched healthy controls.
- Fatigue severity was one of the strongest independent predictors of postural instability — meaning the physical body is destabilized in ways that go well beyond feeling tired.
💡 Long COVID's physical toll extends to balance and core control, not just fatigue.
Brain Activity Patterns Reveal a Neural Signature of Long COVID Pain 🧠
- Patients with new-onset chronic pain from long COVID showed altered EEG alpha wave activity — specifically a slowing of peak alpha frequency — consistent with patterns seen in other chronic pain conditions.
- This suggests the brain's oscillatory rhythm may be a measurable, objective marker of pain severity in long COVID, not just a subjective complaint.
💡 Slowed brain waves may offer a measurable window into long COVID chronic pain.
Specialized Post-COVID Clinics Appear to Reduce Healthcare Costs in England and Wales 💷
- A study comparing healthcare utilization in England and Wales found that long COVID carries substantial costs — and that specialized post-COVID services showed potential to reduce that burden compared to standard care pathways.
- With long COVID affecting millions, the economic case for dedicated clinical infrastructure is becoming harder to dismiss.
💡 Specialized long COVID clinics may pay for themselves by reducing downstream healthcare use.
Neurological Symptoms in Long COVID Strongly Predict Daily Disability 📉
- In a cross-sectional study of 250 Italian long COVID survivors, a composite score of neurological and cognitive symptoms explained over half the variation in functional impairment — a remarkably strong statistical relationship.
- Acute COVID severity also independently predicted disability, reinforcing that how sick someone was initially still echoes months later.
💡 Neurological burden in long COVID is one of the strongest predictors of lost daily function.
Implications
Long COVID is fragmenting into biological subtypes — genetic, metabolic, neurological — while a probiotic trial just offered the clearest interventional signal yet. The unresolved tension: if gut dysbiosis drives fatigue but brain oscillations drive pain and genetics drive cognitive crashes, does one treatment ever address all three?
Studies in this issue
Primary sources used for this newsletter.
- VSL#3® probiotic helps reduce fatigue in long COVID patients: findings from a controlled trialmain storyBritish journal of biomedical science2026-08-11PMID 42577968
- Factors linked to long-term COVID-19 effects and their outcomes in Saudi Arabiakey findingJournal of clinical medicine2026-08-13PMID 42590004
- Balance and trunk movement problems in adults with long COVID measured by computerized and clinical testskey findingPloS one2026-08-13PMID 42594160
- Brain-Related Symptoms and Daily Difficulties in Adults with Long COVID in Italykey findingJournal of clinical medicine2026-08-13PMID 42590129
- Healthcare use and costs for people with Long COVID in England and Wales and the possible benefits of specialized post-COVID carekey findingJournal of the Royal Society of Medicine2026-08-12PMID 42584205
- Haptoglobin Types Identify Differences in Brain Oxygen and Metabolism Linked to Thinking Problems After Exercise in Long COVIDkey findingInternational journal of molecular sciences2026-08-13PMID 42589652
- Brain wave speed linked to pain severity in Long COVID patients with new chronic painkey findingFrontiers in pain research (Lausanne, Switzerland)2026-08-13PMID 42591479
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.